Related Experiment Video
Updated: Jun 26, 2026
08:59
Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis
Published on: July 16, 2021
Interaction between PON1 and population density in amyotrophic lateral sclerosis
Frank P Diekstra1, Ana Beleza-Meireles, Nigel P Leigh
1MRC Centre for Neurodegeneration Research, King's College London, Institute of Psychiatry, London, UK.
Neuroreport
|December 24, 2008
Summary
Genetic variations in paraoxonase (PON) genes may interact with environmental exposures in amyotrophic lateral sclerosis (ALS). A specific PON gene marker, rs854560, showed a significant interaction with population density in ALS patients.
Area of Science:
- Genetics
- Environmental Health
- Neuroscience
Background:
- Paraoxonase (PON) gene polymorphisms are linked to amyotrophic lateral sclerosis (ALS).
- Paraoxonases are enzymes crucial for metabolizing organophosphates and other toxins.
- Environmental exposures may modulate the risk associated with PON gene variations in ALS.
Purpose of the Study:
- To investigate the interaction between paraoxonase gene polymorphisms and environmental exposure in ALS.
- To determine if population density, as a surrogate for environmental exposure, modifies the association between PON genotypes and ALS risk.
Main Methods:
- A case-only study was conducted on 98 ALS patients from South East England.
- Genotyping was performed for specific paraoxonase single nucleotide polymorphisms (SNPs): rs662, rs854560 (L55M), rs6954345, and rs11981433.
- Population density was used to categorize patients into rural or urban environmental exposure groups.
Main Results:
- A significant interaction between the paraoxonase genotype at marker rs854560 (L55M) and population density was observed in ALS patients.
- This suggests that environmental exposure, indicated by population density, may influence the effect of this specific PON gene variant on ALS.
Conclusions:
- The findings support the hypothesis of gene-environment interaction in ALS pathogenesis.
- The rs854560 (L55M) polymorphism in the paraoxonase gene may confer differential risk for ALS depending on environmental exposures related to population density.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...